[ESPR] QoQ Quarter Result on 30-Jun-2017 [#Q2]

Stock
[ESPR] Esperion Therapeutics, Inc.
Announcement Date
08-Aug-2017
Financial Year
2017
Quarter
30-Jun-2017 [#Q2]
Profit Trend
QoQ- -6.90%
YoY- -208.78%
Quarter Report
ESPR's Result
ESPR's Financial Summary
View:
Show?
Quarter Result
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -46,130 -37,891 -45,219 -43,337 -40,541 -28,956 -17,402 91.65%
Tax 0 807 606 433 482 423 488 -
NP -46,130 -37,891 -45,219 -43,337 -40,541 -28,956 -17,402 91.65%
Tax Rate - - - - - - - -
Total Cost 46,130 37,891 45,219 43,337 40,541 28,956 17,402 91.65%
Ratio Analysis
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
EPS -1.73 -1.44 -1.86 -1.92 -1.80 -1.28 -0.77 71.62%
EPS Diluted -1.73 -1.44 -1.86 -1.92 -1.80 -1.28 -0.77 71.62%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.